BARBARI SHARON SURREY Insider Trading
Get the latest insider transactions of BARBARI SHARON SURREY. BARBARI SHARON SURREY is Chief Financial Officer in INTERMUNE INC ($ITMN) and Director in Oculus Innovative Sciences, Inc. ($OCLS) and EVP, Finance & CFO in CYTOKINETICS INC ($CYTK) and Director in AGILE THERAPEUTICS INC ($AGRX) and Director in Menlo Therapeutics Inc. ($MNLO) and Director in Foamix Pharmaceuticals Ltd. ($FOMX). Discover the current value of BARBARI SHARON SURREY shares.
Address: 3280 BAYSHORE BOULEVARD BRISBANE 94005CA
BARBARI SHARON SURREY is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
ITMN | INTERMUNE INC | Chief Financial Officer | 2,041 | 0.00 |
CYTK | CYTOKINETICS INC | EVP, Finance & CFO | 47,640 | 557,388.00 |
OCLS | Sonoma Pharmaceuticals, Inc. | Director | 43,417 | 214,914.15 |
FOMX | Foamix Pharmaceuticals Ltd. | Director | 0 | |
MNLO | VYNE Therapeutics Inc. | Director | 75,000 | |
AGRX | AGILE THERAPEUTICS INC | Director | 26,786 | 63,482.82 |
Insider Trading Transactions of BARBARI SHARON SURREY
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Aug 21 2020 | MNLO | Menlo Therapeutics Inc. | BARBARI SHARON | Director | Buy | 1.48 | 75,000 | 111,000 | 75,000 |
Aug 21 2020 | MNLO | Menlo Therapeutics Inc. | BARBARI SHARON | Director | Option Exercise | 1.48 | 75,000 | 111,000 | 13,971 |
Aug 05 2020 | MNLO | Menlo Therapeutics Inc. | BARBARI SHARON | Director | Option Exercise | 1.72 | 22,500 | 38,700 | 22,500 |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS INC | BARBARI SHARON | Director | Buy | 0.00 | 26,786 | 0 | 26,786 |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS INC | BARBARI SHARON | Director | Option Exercise | 2.80 | 45,212 | 126,594 | 45,212 |
Mar 23 2020 | MNLO | Menlo Therapeutics Inc. | BARBARI SHARON SURREY | Director | Option Exercise | 2.67 | 45,000 | 120,150 | 45,000 |
Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | BARBARI SHARON SURREY | Director | Option Exercise | 2.66 | 49,412 | 131,436 | 0 |
Mar 11 2020 | MNLO | Menlo Therapeutics Inc. | BARBARI SHARON SURREY | Director | Option Exercise | 4.50 | 29,271 | 131,720 | 29,271 |
May 20 2019 | FOMX | Foamix Pharmaceuticals Lt ... | BARBARI SHARON SURREY | Director | Option Exercise | 2.66 | 49,412 | 131,436 | 49,412 |
Mar 02 2018 | OCLS | Sonoma Pharmaceuticals, I ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 1,424 | 0 | 43,417 |
Jan 03 2018 | OCLS | Sonoma Pharmaceuticals, I ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 17,211 | 0 | 41,993 |
Dec 01 2017 | OCLS | Sonoma Pharmaceuticals, I ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 13,944 | 0 | 24,782 |
Aug 30 2017 | OCLS | Sonoma Pharmaceuticals, I ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 880 | 0 | 10,838 |
Jun 01 2017 | OCLS | Sonoma Pharmaceuticals, I ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 754 | 0 | 9,958 |
Mar 02 2017 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Buy | 0.00 | 18,750 | 19 | 47,640 |
Mar 02 2017 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Sell | 10.60 | 7,317 | 77,560 | 40,323 |
Nov 30 2016 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 1,035 | 0 | 6,244 |
Aug 30 2016 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 1,199 | 0 | 5,209 |
Jun 01 2016 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 4,445 | 0 | 20,051 |
Mar 02 2016 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 4,356 | 0 | 4,356 |
Mar 02 2016 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Buy | 0.00 | 11,250 | 0 | 15,606 |
Feb 25 2016 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | 6.67 | 15,013 | 100,137 | 15,013 |
Feb 25 2016 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | 6.67 | 74,987 | 500,163 | 74,987 |
Dec 02 2015 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Option Exercise | 1.24 | 4,920 | 6,101 | 80,968 |
Sep 02 2015 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Option Exercise | 1.21 | 5,109 | 6,182 | 76,048 |
Jun 02 2015 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Option Exercise | 0.90 | 6,972 | 6,275 | 70,939 |
Mar 03 2015 | OCLS | Oculus Innovative Science ... | BARBARI SHARON SURREY | Director | Option Exercise | 0.86 | 7,246 | 6,232 | 63,967 |
Mar 02 2015 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | 7.96 | 12,151 | 96,722 | 12,151 |
Mar 02 2015 | CYTK | CYTOKINETICS INC | BARBARI SHARON SURREY | EVP, Finance & CFO | Option Exercise | 7.96 | 62,849 | 500,278 | 62,849 |
May 03 2004 | ITMN | INTERMUNE INC | BARBARI SHARON SURREY | Chief Financial Offic ... | Buy | 12.58 | 680 | 8,554 | 2,041 |